Management of Complex Wounds Using a Constant Tension External Tissue Expander

Stopped early · Not applicable

Conditions studied: Wounds and Injuries

In brief

Complex wounds that cannot be closed primarily are at great risk for complications. A new technique utilizing external tissue expansion holds promise in rapidly decreasing wound area. Facilitation of rapid wound closure is critical in preventing wound complications. Hypothesis: Using the Dermaclose Wound Management System (Woundcare Technologies, Inc., Chanhassen, MN) in complex wounds not able to be primarily closed will decrease the time to secondary closure and decrease the need for secondary soft tissue coverage procedures, or if secondary soft tissue procedures are required, its use will decrease the size and complexity of the secondary soft tissue procedures. Null Hypothesis: The Dermaclose system will not decrease the need, dimensions, or complexity of secondary soft tissue coverage procedures in complex wounds not able to be primarily closed.

Key facts

Study ID

NCT01171521

Run by

University of Missouri-Columbia

People needed

6

Starts

2010-07-01

Expected to finish

2015-09-01

Last updated by the study team

2016-02-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or greater
• Has soft tissue wound(s) that are unable to be closed primarily

You may not qualify if…

• Age less than 18
• Has wound(s) that can be closed primarily
• Infected wound
• Unable to comply with protocol
• Prior radiation treatment to skin or soft tissues in the area of the wound
• Friable wound margins

Where it is running

• University of Missouri Hospital and Clinics — Columbia, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.